Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5199)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2021 (publication date) through Jan 23, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Au KP, Chok KSH. Immunotherapy after liver transplantation: Where are we now? World J Gastrointest Surg 2021; 13(10): 1267-1278 [PMID: 34754394 DOI: 10.4240/wjgs.v13.i10.1267] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i10/1267.htm |
| Number | Citing Articles |
| 1 |
Karen Abboud, Godsfavour Umoru, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, Humaid O. Al-Shamsi, Milind Javle, Ashish Saharia, Ashton A. Connor, Sudha Kodali, Rafik M. Ghobrial, Maen Abdelrahim. Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology. Cancers 2023; 15(5): 1433 doi: 10.3390/cancers15051433
|
| 2 |
Héloïse Giudicelli, Filomena Conti, Olivier Scatton, Dominique Thabut, Manon Allaire, Gauthier Arcile, Mathilde Aissaoui Jean Charles Bijot, Sarah Boughdad, Charlotte Bouzbib, Hélène Brisson, Harold Bonvallot, Frédéric Charlotte, Audrey Decouen, Pierre-Romain Delmotte, Jérémy Gallet, Maxime Gasperment, Claire Goumard, Sébastien Halter, Florence Jeune, Pascal Lebray, Chétana Lim, Olivier Lucidarme, Philippe Maksud, Maxime Mallet, Anne-Lyse Masse, Alessandra Mazzola, Louis Meyblum, Antoine Monsel, Sarah Mouri, Marie-Virginie Oré, Fabiano Perdigao, Florence Renaud, Géraldine Rousseau, Charles Roux, Marika Rudler, Eric Savier, Jean Marc Simon, Alexandre Sibon, Eleonore Spitzer, Philippe Sultanik, Eloi Varin, Corinne Vezinet, Mathilde Wagner. Standardized immunosuppressive protocol to prevent rejection under immunotherapy for post liver transplantation HCC recurrence: A French center's experience. Journal of Liver Transplantation 2025; 17: 100252 doi: 10.1016/j.liver.2024.100252
|
| 3 |
Abdullah Esmail, Maen Abdelrahim. Transplant Oncology. 2025; : 215 doi: 10.1016/B978-0-443-21901-6.00018-5
|
| 4 |
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis, Emmanouil Sinakos. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World Journal of Transplantation 2022; 12(11): 331-346 doi: 10.5500/wjt.v12.i11.331
|
| 5 |
Saad Alghamdi, Waleed Al-Hamoudi. Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology. Cancers 2023; 15(21): 5115 doi: 10.3390/cancers15215115
|
| 6 |
Charles-Henri Wassmer, Sofia El Hajji, Xenofon Papazarkadas, Philippe Compagnon, Parissa Tabrizian, Stéphanie Lacotte, Christian Toso. Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data. Cancers 2023; 15(18): 4574 doi: 10.3390/cancers15184574
|
| 7 |
Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first report. American Journal of Transplantation 2024; 24(6): 1087 doi: 10.1016/j.ajt.2024.01.007
|
| 8 |
Chia Yuen Chong, Michelle S. Goh, Sandro V. Porceddu, Danny Rischin, Annette M. Lim. The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma. American Journal of Clinical Dermatology 2023; 24(1): 25 doi: 10.1007/s40257-022-00742-8
|
| 9 |
Julian K. Horwitz, Vatche G. Agopian. Indication of Liver Transplant for HCC: Current Status and Future Directions. Current Hepatology Reports 2024; 23(1): 185 doi: 10.1007/s11901-024-00641-y
|
| 10 |
Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Thomas Talbot, Alessandra Gennari, Mark R. Openshaw, Coskun O. Demirtas, Alessio Cortellini, David J. Pinato. New Frontiers in the Medical Therapy of Hepatocellular Carcinoma. Chemotherapy 2022; 67(3): 164 doi: 10.1159/000521837
|
| 11 |
Landon L. Chan, Stephen L. Chan. The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment. Clinical and Molecular Hepatology 2023; 29(4): 909 doi: 10.3350/cmh.2023.0114
|
| 12 |
Stefano Kayali, Andrea Pasta, Maria Corina Plaz Torres, Ariel Jaffe, Mario Strazzabosco, Simona Marenco, Edoardo G. Giannini. Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysis. Liver International 2023; 43(1): 8 doi: 10.1111/liv.15419
|
| 13 |
Stephanie Ji, Hao Liu, Laura Pachella, Ryan D. Stephenson, Roman Groisberg, Sarah A. Weiss. Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies. Frontiers in Transplantation 2023; 2 doi: 10.3389/frtra.2023.1284740
|
| 14 |
Anthony C. Bejjani, Richard S. Finn. Hepatocellular Carcinoma: Pick the Winner—Tyrosine Kinase Inhibitor Versus Immuno-oncology Agent–Based Combinations. Journal of Clinical Oncology 2022; 40(24): 2763 doi: 10.1200/JCO.21.02605
|
| 15 |
Anand V. Kulkarni, Parthasarathy Kumaraswamy, Balachandran Menon, Anuradha Sekaran, Anuhya Rambhatla, Sowmya Iyengar, Manasa Alla, Shantan Venishetty, Sumana Kolar Ramachandra, Giri V. Premkumar, Mithun Sharma, P. Nagaraja Rao, Duvvur Nageshwar Reddy, Amit G. Singal. Downstaging with atezolizumab-bevacizumab: a case series. Journal of Liver Cancer 2024; 24(2): 224 doi: 10.17998/jlc.2024.05.12
|
| 16 |
Coskun Ozer Demirtas, Feyza Gunduz. Programmed Cell Death 1 and Hepatocellular Carcinoma: An Epochal Story. Journal of Gastrointestinal Cancer 2021; 52(4): 1217 doi: 10.1007/s12029-021-00758-z
|
| 17 |
Peter D. Block, Mario Strazzabosco, Ariel Jaffe. Approach to immunotherapy for HCC in the liver transplant population. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000158
|
| 18 |
Sai Swarupa R Vulasala, Nirmal K Onteddu, Sindhu P Kumar, Chandana Lall, Priya Bhosale, Mayur K Virarkar. Advances and effectiveness of the immunotherapy after liver transplantation. World Journal of Gastrointestinal Surgery 2022; 14(6): 629-631 doi: 10.4240/wjgs.v14.i6.629
|
| 19 |
Ahmed Ramadan, Mona Kaddah, Hend Shousha, Mohamed El-Kassas. Personalized treatment approaches in hepatocellular carcinoma. Arab Journal of Gastroenterology 2025; doi: 10.1016/j.ajg.2024.08.003
|
| 20 |
Nora Alzahrani, Ayman Al Jurdi, Leonardo V. Riella. Immune checkpoint inhibitors in kidney transplantation. Current Opinion in Organ Transplantation 2023; 28(1): 46 doi: 10.1097/MOT.0000000000001036
|
| 21 |
Anand V. Kulkarni, Vamsi Krishna, Karan Kumar, Mithun Sharma, Bharat Patodiya, Arif Khan, Sameer Shaik, Ashirwad Pasumarthy, Prateek Chhabra, Pramod Kumar Da, Vivek A. Saraswat, Padaki N. Rao, Duvvur N. Reddy. Safety and Efficacy of Atezolizumab-Bevacizumab in Real World: The First Indian Experience. Journal of Clinical and Experimental Hepatology 2023; 13(4): 618 doi: 10.1016/j.jceh.2023.02.003
|
| 22 |
Susan J. Kim, Kaelyn C. Cummins, Allan Tsung. Immunotherapy as a Complement to Surgical Management of Hepatocellular Carcinoma. Cancers 2024; 16(10): 1852 doi: 10.3390/cancers16101852
|
| 23 |
Maen Abdelrahim, Abdullah Esmail. Transplant Oncology. 2025; : 87 doi: 10.1016/B978-0-443-21901-6.00008-2
|
| 24 |
Kathrine S Rallis, Dimitrios Makrakis, Ioannis A Ziogas, Georgios Tsoulfas. Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances. World Journal of Clinical Oncology 2022; 13(6): 448-472 doi: 10.5306/wjco.v13.i6.448
|
| 25 |
Zurabi Lominadze, Kareen Hill, Mohammed Rifat Shaik, Justin P. Canakis, Mohammad Bourmaf, Cyrus Adams-Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review. International Journal of Molecular Sciences 2023; 24(3): 2358 doi: 10.3390/ijms24032358
|